Completed PHASE2 INTERVENTIONAL 1-arm NCT00043017

Magnetic Resonance Imaging in Women Receiving Chemotherapy for Stage III Breast Cancer (ACRIN 6657)

Contrast-Enhanced Breast MRI For Evaluation Of Patients Undergoing Neoadjuvant Treatment For Locally-Advanced Breast Cancer (I-SPY 1/ACRIN 6657)

Sponsor: American College of Radiology Imaging Network

Conditions Breast Cancer

Interventions MRI/MRS gadopentetate dimeglumine

Updated 6 times since 2017 Last updated: Oct 7, 2013 Started: May 31, 2002 Primary completion: May 31, 2005 Completion: Mar 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Breast Cancer and is currently completed. American College of Radiology Imaging Network leads this study, which shows 6 recorded versions since 2002 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE2
Sep 2024 — Sep 2025 [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

May 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

American College of Radiology Imaging Network
National Cancer Institute (NCI)

Data source: American College of Radiology Imaging Network

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Birmingham, United States , Chapel Hill, United States , Chicago, United States , Dallas, United States , Lebanon, United States , Minneapolis, United States , New York, United States , Philadelphia, United States , Rochester, United States , San Francisco, United States and 1 more location